Recruiting

Shelf Builder Women's Creatine

Sponsor:

Clean Nutraceuticals

Code:

NCT07766395

Conditions

Lean Muscle Development

Muscular Endurance

Hormone-Related Wellness

Digestive Comfort

Dermatologic Health

Eligibility Criteria

Sex: All

Age: 21 - 45

Healthy Volunteers: Accepted

Interventions

Shelf Builder Women's Creatine Powder

Study Details

Brief summary:

This study will evaluate the effects of Clean Nutra's Shelf Builder Women's Creatine Powder on lean muscle development, hormone-related wellness, digestive comfort, dermatological health, and overall wellness. The study is a single-arm, open-label, virtual trial in which all 35 enrolled participants will use the test product once daily for eight weeks.

Participants will complete self-reported questionnaires at Baseline and at the end of Week 4 and Week 8 to assess changes in lean muscle development, muscular endurance, hormone-related wellness, digestive comfort, hair/nail/skin health, and overall wellness.

Conditions

Lean Muscle Development

Muscular Endurance

Hormone-Related Wellness

Digestive Comfort

Dermatologic Health

Study ID

NCT07766395

Start date

Sep, 2026

Status verified date

Aug, 2026

Completion date

Nov, 2026

Anticipated

Primary completion date

Nov, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21 - 45

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Be female.
  • Be aged 21-45.
  • Engages in structured physical activity ≥3 times per week, with each session lasting at least 30 minutes, (e.g., running, gym/strength training, cycling, team sports, fitness classes).
  • Anyone with a menstrual cycle between 24-38 days.
  • Anyone who has experienced concerns with at least two of the following, twice per week, over the past four weeks: Hair, skin, and nail health
  • Bloating
  • Symptoms of hormonal imbalance.
  • Anyone with a BMI of 18.5 to 30 kg/m2.
  • Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
  • If taking medications, other supplements, or herbal remedies targeted at lean muscle development, muscular endurance, digestive comfort, hormonal balance, or dermatological health, has been consistently taking for at least three months prior to starting the study, and is willing to maintain this routine for the study duration.
  • Anyone who is willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial.
  • Resides in the United States.

Exclusion Criteria:

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and mental health disorders.
  • Anyone with a known history of severe digestive disorders like acid reflux, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn's disease, or gastrointestinal tract surgeries.
  • Planning on introducing any products or any new forms of prescription medication or supplements that target lean muscle development, muscular endurance, digestive comfort, hormonal balance, or dermatological health for the study duration.
  • Anyone who has been diagnosed with kidney disease and/or has previously or is currently taking diuretics or kidney medications.
  • Anyone who has previously or is currently taking any hormone therapies.
  • Anyone who is currently taking medications or supplements that contain zinc or iron.
  • Anyone with any allergies or sensitivities to fish, eggs, or any of the study product ingredients.
  • Anyone currently consuming products with creatine.
  • Anyone diagnosed with a thyroid-related condition.
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
  • Anyone who has a history of serious illness in the last three months.
  • Anyone who has planned surgery during the study period.
  • Anyone with a history of substance abuse.
  • Anyone who is currently a smoker or has been a smoker in the past 3 months.
  • Anyone who has stopped or started using hormonal birth control in the past 2 months.
  • Anyone who is vegan and/or does not consume animal products for any reason.
  • Anyone currently taking a weight loss medication, including but not limited to Wegovy, Mounjaro, and Ozempic.
  • Currently undergoing hair treatment or using other hair growth/thickening products.
  • Currently taking any prescription medication for hair loss.
  • Anyone with any conditions that affect the hair or scalp (e.g., alopecia areata).
  • Anyone who drinks heavily (8 or more alcoholic drinks per week).

Study Design

Enrollment

35 participants

Anticipated

Intervention Model

Single group

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: Shelf Builder Women's Creatine Powder

Interventions

Shelf Builder Women's Creatine Powder

All participants take one scoop (9 g) of Clean Nutra Shelf Builder Women's Creatine Powder mixed in 8 oz of cold water once daily with the first meal of the day for eight weeks.

Primary outcome measure

  • Change in Lean Muscle Development [ Time Frame: Baseline, Week 4, and Week 8 ]
  • Change in Muscular Endurance [ Time Frame: Baseline, Week 4, and Week 8 ]
  • Change in Digestive Comfort [ Time Frame: Baseline, Week 4, and Week 8 ]
  • Change in Hair [ Time Frame: Baseline, Week 4, and Week 8 ]
  • Change in Nail [ Time Frame: Baseline, Week 4, and Week 8 ]
  • Change in Skin Health [ Time Frame: Baseline, Week 4, and Week 8 ]
  • Change in Symptoms of Hormonal Imbalance [ Time Frame: Baseline, Week 4, and Week 8 ]
  • Change in Overall Health and Wellness [ Time Frame: Baseline, Week 4, and Week 8 ]

Central Contacts and Locations

Central contacts

Patrick Renner

hello@citruslabs.com

Locations

Citruslabs

Recruiting

Las Vegas, Nevada, United States, 89101

More Information

Sponsor

Clean Nutraceuticals

Last update posted

Aug 14, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Clean Nutraceuticals on 2026-08-14.